hVIVO signs £5.2m contract with a global biotechnology company
HVIVO signs £5.2m contract with a global biotechnology company
Source: directorstalkinterviews.com
Stay updated with breaking news from Challenge Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HVIVO signs £5.2m contract with a global biotechnology company
HVIVO secures £13.6m RSV contract with a US-based biopharmaceutical client
GREAT EX RD FESTIVAL - No stranger to trailblazers, the Department of Infectious Disease had a strong presence at the 2022 Great Exhibition Road Festival.
Open Orphan's hVIVO secures £7.2m contract with existing top 5 global pharmaceutical company
Open Orphan wins £5m RSV human challenge study contract with European biotechnology company